| Revenue growth | FY26 revenue up 5% annualized to ₹288cr. |
|---|---|
| Margins | EBITDA margins stable at 22%; targeting 25% post-expansion. |
| Order book | Rolling orders with 3-6 month visibility in some markets. |
| Demand visibility | Strong IV fluid demand growing 8-10% annually in India. |
| Management confidence | High; citing strategic foundation and product differentiation. |
Growth
FY26 PAT grew 42% YoY to ₹15cr; revenue up 5% annualized. Q4 FY26 revenue at ₹77cr.
Outlook
Expanding SteriPort capacity from 6.6cr to 12cr bottles; targeting 24-25% company-wide EBITDA margins with new capacity.
Risks
Input costs for polymers surged 60-70%; potential inventory lag during price corrections; dependence on UK ophthalmic market.
Earnings Call filed with NSE, NSE: AMANTA. Summary written with AI assistance from the document.
Amanta Healthcare Ltd: key numbers
- Share price
- ₹186.00
- Market cap
- ₹722.2 Cr
- Revenue (annual)
- ₹287.7 Cr
- Net profit (annual)
- ₹14.88 Cr
- P/E (TTM)
- 49.2×Sector 50.4×
- Promoter holding
- 63.80%+0.08% QoQ
- FII holding
- 0.43%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Amanta Healthcare Ltd
All →Amanta Healthcare Management Change
Amanta Healthcare Limited appointed Nimesh P Patel as Non-Executive Non-Independent Director. The company also appointed M/s. Kashyap R. Mehta & Partners as the Secretarial Auditor.
Amanta Healthcare Annual General Meeting
Amanta Healthcare held its 31st Annual General Meeting on September 16, 2026, transacting ordinary and special business items via video conferencing.
Amanta Healthcare Production Started
Amanta Healthcare has commenced production at its new SteriPort facility at the Kheda campus. This brownfield expansion aims to improve operational efficiency and EBITDA margins.
Amanta Healthcare Earnings Call Transcript: Key Takeaways
Amanta Healthcare delivers solid FY26 results with significant profit growth, transitioning toward high-margin specialized products like Steriport and ophthalmic solutions.
Amanta Healthcare Investor Presentation: Key Takeaways
Amanta reported Q1FY27 revenue of INR 69 Cr (5% YoY) with 21% EBITDA margins. Strategy focuses on high-margin SteriPort/SVP capacity expansion and cost optimization via solar power.
- Call
- Guides 20% growth
Amanta Healthcare Q1 FY27 Results: Net Profit ₹3.3 Cr, Down 5.7% YoY
Amanta Healthcare Ltd reported revenue from operations of ₹68.8 Cr (+5.4% YoY) and net profit of ₹3.3 Cr (-5.7% YoY) for Q1 FY27.
- Key figure
- Net profit ₹3.3 Cr · -5.7% YoY